1,026 results on '"Yang, Ju Dong"'
Search Results
202. Abstract 764: Circulating tumor cell-based mRNA scoring system for prognostication of hepatocellular carcinoma - Translating HCC tissue-based mRNA profiling into a non-invasive setting
203. Current impact of viral hepatitis on liver cancer development: The challenge remains
204. State‐Level HCC Incidence and Association With Obesity and Physical Activity in the United States
205. Diagnostic Criteria and LI‐RADS for Hepatocellular Carcinoma
206. A morphological subset of circulating tumor cells in advanced prostate cancer reveals a potential biomarker for clinical outcomes.
207. The Mortality and Overall Survival Trends of Primary Liver Cancer in the United States
208. DNA Methylation Markers for Detection of Cholangiocarcinoma: Discovery, Validation, and Clinical Testing in Biliary Brushings and Plasma
209. High Neutrophil–Lymphocyte Ratio and Delta Neutrophil–Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer
210. 433 THE ASSOCIATION OF SUSTAINED VIROLOGIC RESPONSE ON TREATMENT OUTCOMES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA WITH HEPATITIS C
211. Fr388 THERAPEUTIC UNDERUTILIZATION AND DELAY IN HEPATOCELLULAR CARCINOMA: TRENDS, ASSOCIATED FACTORS AND THEIR CLINICAL IMPACT FROM NATIONAL CANCER DATABASE ANALYSIS
212. Fr390 COMPARISON OF SURGICAL RESECTION AND SYSTEMIC TREATMENT FOR HEPATOCELLULAR CARCINOMA WITH VASCULAR INVASION: NATIONAL CANCER DATABASE ANALYSIS
213. Current impact of viral hepatitis on liver cancer development:The challenge remains
214. Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation
215. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis
216. Transarterial Radioembolization Versus Systemic Treatment for Hepatocellular Carcinoma with Macrovascular Invasion: Analysis of the U.S. National Cancer Database
217. Differential characteristics and outcomes of Asian and non‐Asian patients with HBV‐related hepatocellular carcinoma
218. Blood Salvage and Autotransfusion With Single Leukoreduction Does Not Increase the Risk of Tumor Recurrence After Liver Transplantation for Advanced Hepatocellular Carcinoma
219. Nuclear size of circulating tumor cells in advanced prostate cancer to reveal a potential biomarker for clinical outcomes and androgen receptor indifference.
220. SAT-408 - Machine learning with routine laboratory tests and clinical features performs similar to current NAFLD clinical pathways
221. TOP-065 - Multidimensional genomic analysis of cell-free DNA for early detection of hepatocellular carcinoma
222. Tu1551 COST-EFFECTIVENESS OF HEPATOCELLULAR CARCINOMA SURVEILLANCE PROGRAMS USING MULTI-TARGET BLOOD TEST
223. Tu1550 UTILITY OF A BIOMARKER-DERIVED SCORE FOR TREATMENT RESPONSE ASSESSMENT IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
224. Tu1538 CS-ICCA: A NEW CLINICALLY BASED STAGING SYSTEM FOR INTRAHEPATIC CHOLANGIOCARCINOMA;ESTABLISHMENT AND EXTERNAL VALIDATION
225. Tu1506 THE DISPARITY IN THE DELIVERY OF IMMUNOTHERAPY FOR ADVANCED HEPATOCELLULAR CARCINOMA
226. 340 COVID-19 PANDEMIC IMPACT ON DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN THE UNITED STATES
227. Mo1135 RADIOLOGIC ANALYSIS FOR RISK STRATIFICATION OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CIRRHOSIS
228. Sa1149 MULTIDISCIPLINARY CARE FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
229. Evaluation and management of liver masses
230. Increase in Alcoholic Hepatitis as an Etiology for Liver Transplantation in the United States: A 2004-2018 Analysis.
231. Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring.
232. Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma
233. Estrogen-Driven Growth of Focal Nodular Hyperplasia: Truth or Myth?
234. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma
235. Comparison of Surgical Resection and Systemic Treatment for Hepatocellular Carcinoma with Vascular Invasion: National Cancer Database Analysis
236. Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C
237. Immunotherapy in advanced hepatocellular carcinoma: an evolving space in the systemic treatment paradigm
238. Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer Risk
239. Circulating Tumor Cell–Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue‐Based Messenger RNA Profiling Into a Noninvasive Setting.
240. Brivanib attenuates hepatic fibrosis in vivo and stellate cell proliferation in vitro by inhibition of FGF and VEGF signaling: 1234
241. Re-Examination of Surveillance for Hepatocellular Carcinoma in Patients with Cirrhosis: 621
242. Model to estimate survival in ambulatory patients with hepatocellular carcinoma
243. Hepatocellular Carcinoma: Still in Search of Evidence-Based Care
244. Metabolic Syndrome and Alcohol Abuse: A Potential Hepatocarcinogenic Mix in Adolescents
245. Hepatocellular Carcinoma in Olmsted County, Minnesota, 1976–2008
246. New advances in the diagnosis and management of hepatocellular carcinoma
247. Increase in Alcoholic Hepatitis as an Etiology for Liver Transplantation in the United States: A 2004–2018 Analysis
248. Effects of Cirrhosis and Diagnosis Scenario in Metabolic‐Associated Fatty Liver Disease‐Related Hepatocellular Carcinoma
249. Hepatic sinusoidal obstruction syndrome due to tacrolimus in a liver-transplantation recipient
250. Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.